Skip to main content

Human Genome Sciences Revenues Up, Net Loss Falls

NEW YORK, Feb. 11 (GenomeWeb News) - Rockville, Md.-based Human Genome Sciences reported sharply increased revenues and cut its net loss for the fourth quarter ending Dec. 31, the company said today.

 

The company's revenues increased to $4.6 million for the quarter, compared to $642,000 for the year-ago period, while recording a net loss of $49 million, or $0.38 per share, computed on a GAAP basis for the quarter, compared to a loss of $60 million for the same period in 2002, or $0.46 per share, the company said in a statement. The company received a one-time license fee relating to an amended agreement signed during the fourth quarter of 2003.

 

The company had cash and short-term investments totaling $1.26 billion, including $280.8 million of restricted investments, on hand as of Dec. 31.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.